Loading…
Indoco Remedies (INDOCO)₹219.34+0.22%Pharmaceuticals
At the end of the Sep 2026 quarter, Indoco Remedies' shareholders were: promoters 58.89%, FIIs 1.62%, DIIs 16.62%, public 22.73%, others 0.14%. Promoter holding is up 0.06 percentage points from 58.83% a quarter earlier. FII holding is up 0.38 percentage points from 1.24% a year earlier. 0.00% of promoter shares were pledged. It had 34,088 shareholders.
As of · Company filings (shareholding pattern)
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 58.72% | 58.69% | 58.73% | 58.73% | 58.77% | 58.87% | 58.87% | 58.87% | 58.87% | 58.83% | 58.83% | 58.89% |
| FIIs | 1.67% | 1.90% | 1.47% | 1.68% | 1.24% | 1.23% | 1.21% | 1.24% | 1.09% | 0.93% | 1.26% | 1.62% |
| DIIs | 19.54% | 19.39% | 18.65% | 18.23% | 18.89% | 18.73% | 18.94% | 18.14% | 18.13% | 18.13% | 17.66% | 16.62% |
| Public | 20.07% | 19.99% | 21.12% | 21.33% | 21.07% | 21.08% | 20.89% | 21.66% | 21.82% | 21.97% | 22.11% | 22.73% |
| Others | 0.00% | 0.03% | 0.03% | 0.03% | 0.03% | 0.09% | 0.09% | 0.09% | 0.09% | 0.14% | 0.14% | 0.14% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 0.00% |
| Number of shareholders | 32,591 | 33,192 | 34,501 | 34,406 | 34,666 | 34,487 | 33,120 | 33,310 | 32,650 | 32,267 | 32,448 | 34,088 |
| Holder | Category | Sep 2026 | Change (pp) |
|---|---|---|---|
| Spa Holdings Pvt Ltd | Promoter | 19.87% | 0.00 |
| Shanteri Investment Pvt Ltd | Promoter | 17.22% | 0.00 |
| Kare Family Private Trust | Promoter | 14.13% | 0.00 |
| Nippon Life India Trustee Ltd-A/C Nippon India Small Cap Fund | DII | 4.64% | −0.17 |
| Quant Mutual Fund - Quant Small Cap Fund | DII | 4.51% | 0.00 |
| Dsp Healthcare Fund | DII | 4.31% | 0.00 |
| Panandikar Aditi Milind | Promoter | 3.19% | +0.01 |
| Madhura Suresh Kare | Promoter | 2.71% | +0.01 |
| Hdfc Value Fund | DII | 1.67% | 0.00 |
| Kare Suresh Govind | Promoter | 1.43% | +0.02 |
| Icici Prudential Healthcare Fund | DII | 1.26% | New |
| Mangeshi Investment Private Limited | Public | 1.25% | 0.00 |
| SURESH GOVIND KARE HUF (Karta- Suresh Govind Kare) | Promoter | 0.30% | 0.00 |
| Sharda Ramnath Kare | Promoter | 0.04% | 0.00 |
| Pratima Ajit Vaidya | Promoter | 0.03% | 0.00 |
| Kare Aruna Suresh | Promoter | 0.02% | New |
| Milind S Panandikar | Promoter | 0.01% | 0.00 |
| Pooja Rajendra Pai | Promoter | 0.01% | 0.00 |
| Icici Prudential Pharma Healthcare And Diaganostics (P.H.D.) Fund | DII | Exited | — |
| Mahika Milind Panandikar | Promoter | 0.00% | 0.00 |
| Megh Milind Panandikar | Promoter | 0.00% | 0.00 |
Promoters held 58.89% of Indoco Remedies at the end of the Sep 2026 quarter, up 0.02 percentage points from 58.87% a year earlier.
In the Sep 2026 quarter, foreign institutional investors (FIIs) held 1.62% (up 0.36 percentage points from 1.26% a quarter earlier) and domestic institutions (DIIs) held 16.62% (down 1.04 percentage points from 17.66% a quarter earlier).
No. The Sep 2026 filing shows no pledged promoter shares.
Indoco Remedies had 34,088 shareholders at the end of the Sep 2026 quarter, against 33,310 a year earlier.
Nippon Life India Trustee Ltd-A/C Nippon India Small Cap Fund (DII) held 4.64% at the end of the Sep 2026 quarter, the largest named holding outside the promoter group.